Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Revenue

In the year 2024, Aprea Therapeutics had annual revenue of $1.50M with 157.63% growth. Aprea Therapeutics had revenue of $205.82K in the quarter ending December 31, 2024, with 1,362.29% growth.

• Revenue (ttm): $1.50M
• Revenue Growth: +157.63%
• P/S Ratio: 7.66
• Revenue / Employee: $214,654
• Employees: 7
• Market Cap: 11.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.50M	919.35K	157.63%
Dec 31, 2023	583.23K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.